Showing 14,081 - 14,100 results of 49,463 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (mean decrease)) ))', query time: 0.84s Refine Results
  1. 14081

    CA-induced MTT and crystal violet reduction and protection by Ber in N2a cells. by Xiaofeng Liu (35910)

    Published 2014
    “…<p>CA decreased cell viability in a dose-dependent manner as determined by MTT and crystal violet assay (<b>A</b>) and Ber increased cell viability in a dose-dependent manner until to 25 μg/ml in 2.5 nmol/L CA-treated cells (<b>B</b>). 25 μg/ml Ber showed significant protection of the cells from CA-induced lesions. …”
  2. 14082
  3. 14083
  4. 14084

    Analysis of Jak2 Catalytic Function by Peptide Microarrays: The Role of the JH2 Domain and V617F Mutation by Arturo Sanz (224344)

    Published 2011
    “…The physiological role of the JH2 domain in the regulation of JAK2 activity was highlighted by the discovery of the acquired missense point mutation V617F in myeloproliferative neoplasms (MPN). …”
  5. 14085

    Impact of LVAD support level on infarct size in a dog model of ischemia reperfusion. by Keita Saku (714525)

    Published 2016
    “…Compared to control (no LVAD support, n = 6), p-LVAD (n = 5) moderately lowers the infarct ratio (<i>p</i> = 0.011), while t-LVAD (n = 5) strikingly decreases the infarct ratio by more than 80% (<i>p</i><0.01). …”
  6. 14086

    Image_5_Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity.jpeg by Francesca Faustini (204803)

    Published 2022
    “…The DN B cells were further subdivided based on CXCR5 expression. Significant shifts were observed at the early follow-up in the DN2 sub-cluster (CD11c+CXCR5-), which reduced significantly (-15.4 percentage points, p=0.02) and in the recently described DN3 (CD11c-CXCR5-) which increased (+13 percentage points, p=0.03). …”
  7. 14087
  8. 14088
  9. 14089
  10. 14090

    Data_Sheet_1_The course and determinants of post-traumatic stress over 12 months after hospitalization for COVID-19.PDF by Knut Stavem (4256077)

    Published 2022
    “…</p>Conclusions<p>The level of PTSD symptoms decreased from 1.5 to 3 months after hospitalization, but did not decrease further to 12 months, and there was no association between PTSD symptoms and COVID-19 disease severity.…”
  11. 14091
  12. 14092
  13. 14093
  14. 14094
  15. 14095

    DataSheet_2_Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection.pdf by Ilias Christodoulou (11869739)

    Published 2021
    “…<p>H84T-Banana Lectin (BanLec) CAR-NK cells bind high mannose glycosites that decorate the SARS-CoV-2 envelope, thereby decreasing cellular infection in a model of SARS-CoV-2. …”
  16. 14096

    DataSheet_1_Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection.pdf by Ilias Christodoulou (11869739)

    Published 2021
    “…<p>H84T-Banana Lectin (BanLec) CAR-NK cells bind high mannose glycosites that decorate the SARS-CoV-2 envelope, thereby decreasing cellular infection in a model of SARS-CoV-2. …”
  17. 14097

    Image_5_Reductive Power Generated by Mycobacterium leprae Through Cholesterol Oxidation Contributes to Lipid and ATP Synthesis.tif by Thabatta L. S. A. Rosa (11195667)

    Published 2021
    “…Inhibition of M. leprae 3β-HSD activity with the 17β-[N-(2,5-di-t-butylphenyl)carbamoyl]-6-azaandrost-4-en-3one (compound 1), decreased bacterial intracellular survival in SCs. …”
  18. 14098

    Image_5_Reductive Power Generated by Mycobacterium leprae Through Cholesterol Oxidation Contributes to Lipid and ATP Synthesis.tif by Thabatta L. S. A. Rosa (11195667)

    Published 2021
    “…Inhibition of M. leprae 3β-HSD activity with the 17β-[N-(2,5-di-t-butylphenyl)carbamoyl]-6-azaandrost-4-en-3one (compound 1), decreased bacterial intracellular survival in SCs. …”
  19. 14099
  20. 14100

    Influence of Familial Renal Glycosuria Due to Mutations in the <i>SLC5A2</i> Gene on Changes in Glucose Tolerance over Time by Emilia Ottosson-Laakso (843794)

    Published 2016
    “…Several drugs have been introduced as means to lower glucose in patients with type 2 diabetes targeting SGLT2 resulting in renal glycosuria, but no studies have addressed the potential effects of decreased renal glucose reabsorption and chronic glycosuria on the prevention of glucose intolerance. …”